HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$35.91
Day range
$35.11 - $36.92
Year range
$23.14 - $36.92
Market cap
1.73B USD
Avg Volume
950.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 69.22M | 119.07% |
Operating expense | 77.86M | 44.81% |
Net income | -25.28M | 16.10% |
Net profit margin | -36.52 | 61.70% |
Earnings per share | -0.54 | 32.50% |
EBITDA | -20.80M | 19.40% |
Effective tax rate | -2.53% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 302.84M | 129.30% |
Total assets | 651.96M | 95.47% |
Total liabilities | 417.36M | 116.95% |
Total equity | 234.60M | — |
Shares outstanding | 47.13M | — |
Price to book | 7.20 | — |
Return on assets | -10.19% | — |
Return on capital | -12.04% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -25.28M | 16.10% |
Cash from operations | 15.21M | 181.03% |
Cash from investing | -13.00K | -100.05% |
Cash from financing | 1.20M | -90.72% |
Net change in cash | 16.52M | -22.88% |
Free cash flow | 32.92M | 177.67% |
About
Founded
2018
Headquarters
Website
Employees
278